GREENMAN TECHNOLOGIES,
INC.
|
(Name of Registrant as Specified
in its Charter)
|
(Name of Person(s) Filing Proxy
Statement, if Other than the
Registrant)
|
☒
|
No fee
required.
|
|
☐
|
Fee computed on table below per
Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities
to which transaction applies:
|
|
(2)
|
Aggregate number of securities to
which transaction applies:
|
|
(3)
|
Per unit price or other underlying
value of transaction computed pursuant to Exchange Act Rule 0-11 (set
forth the amount on which the filing fee is calculated and state how it
was determined):
|
|
(4)
|
Proposed maximum aggregate value
of transaction:
|
|
(5)
|
Total fee
paid:
|
|
☐
|
Fee paid previously with
preliminary materials.
|
|
☐
|
Check box if any part of the fee
is offset as provided by Exchange Act Rule 0-11(a)(2) and identify
the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the form or schedule
and the date of its filing.
|
|
(1)
|
Amount Previously
Paid:
|
|
(2)
|
Form, Schedule or Registration
Statement No.:
|
|
(3)
|
Filing
Party:
|
|
(4)
|
Date
Filed:
|
|
1.
|
To
elect four members of our Board of
Directors;
|
|
2.
|
To
consider and act upon a proposal to ratify the selection of the firm of
Schechter, Dokken, Kanter, Andrews & Selcer, Ltd. as our independent
auditors for the fiscal year ending September 30, 2009;
and
|
|
3.
|
To
transact such other business as may properly come before the Meeting and
any adjournments thereof.
|
|
·
|
by
each of our directors and executive
officers;
|
|
·
|
by
all of our directors and executive officers as a group;
and
|
|
·
|
by
each person (including any “group” as used in Section 13(d) of the
Securities Exchange Act of 1934) who is known by us to own beneficially 5%
or more of the outstanding shares of common
stock.
|
Name
(1)
|
Number
of Shares
Beneficially Owned
(2)
|
Percentage
of Class
(2)
|
||
Dr.
Allen Kahn (3)
|
4,371,931
|
14.15%
|
||
Maurice
E. Needham (4)
|
1,672,301
|
5.36%
|
||
Lyle
Jensen (5)
|
1,213,522
|
3.86%
|
||
Charles
E. Coppa (6)
|
688,228
|
2.21%
|
||
Nicholas DeBenedictis
(7)
|
822,454
|
2.66%
|
||
Lew
F. Boyd (8)
|
293,678
|
0.95%
|
||
All
officers and directors as
a group (6 persons)
|
9,062,114
|
28.14%
|
Name
(1)
|
Number
of Shares
Beneficially Owned
(2)
|
Percentage
of Class
(2)
|
|
Laurus
Master Fund, Ltd. (9)
|
1,540,934
|
4.99%
|
(1)
|
Except
as noted, each person’s address is care of GreenMan Technologies,
Inc., 205 South Garfield, Carlisle, Iowa
50047.
|
(2)
|
Pursuant to the rules of the
Securities and Exchange Commission, shares of common stock that an
individual or group has a right to acquire within 60 days pursuant to the
exercise of options or warrants are deemed to be outstanding for the
purpose of computing the percentage ownership of such individual or group,
but are not deemed to be outstanding for the purpose of computing the
percentage ownership of any other person shown in the
table.
|
(3)
|
Includes 23,500 shares of common
stock issuable pursuant to immediately exercisable stock
options.
|
(4)
|
Includes 343,962 shares of common
stock issuable pursuant to immediately exercisable stock options. Also
includes 59,556 shares of common stock owned by Mr. Needham’s
wife.
|
(5)
|
Includes 578,500 shares of common
stock issuable pursuant to immediately exercisable stock
options.
|
(6)
|
Includes 301,300 shares of common
stock issuable pursuant to immediately exercisable stock
options.
|
(7)
|
Includes 371,000 shares of common
stock owned by Mr. DeBenedictis’ wife and 54,000 shares of common stock
issuable pursuant to immediately exercisable stock options. Mr.
DeBenedictis resigned from the Board of Directors on February 25,
2009.
|
(8)
|
Includes 17,500 shares of common
stock issuable pursuant to immediately exercisable stock
options.
|
(9)
|
Laurus
Master Fund, Ltd. holds warrants to purchase up to 4,811,906 shares of
common stock that are exercisable (subject to the following sentence) at
an exercise price of $.01 per share. The warrants are not exercisable,
however, to the extent that (a) the number of shares of our common stock
held by Laurus and (b) the number of shares of our common stock issuable
upon exercise of the warrant would result in beneficial ownership by
Laurus of more than 4.99% of our outstanding shares of common stock.
Laurus may waive these provisions, or increase or decrease that
percentage, with respect to the warrant on 61 days’ prior notice to us.
Unless and until Laurus waives these provisions, then Laurus beneficially
owns 1,540,934 shares of our common stock issuable pursuant to underlying
warrant. Laurus’ address is 335 Madison Avenue, New York, New York
10017.
|
Nominee’s
Name
|
Position(s)
Held
|
Year
Term
Will
Expire
|
Maurice
E. Needham
|
Chairman
of the Board of Directors
|
2010
|
Lyle
Jensen
|
Chief
Executive Officer, President and Director
|
2010
|
Dr.
Allen Kahn
|
Director
|
2010
|
Lew
F. Boyd
|
Director
|
2010
|
Name
|
Age
|
Position
|
Maurice
E. Needham
|
68
|
Chairman
of the Board of Directors
|
Lyle
Jensen
|
58
|
Chief
Executive Officer; President; Director
|
Charles
E. Coppa
|
45
|
Chief
Financial Officer; Treasurer; Secretary
|
Dr.
Allen Kahn
|
87
|
Director
|
Lew
F. Boyd
|
63
|
Director
|
Annual
Compensation
|
Option
|
All
Other
|
||||||||||||||||||||||
Name and Principal
Position
|
Fiscal
Year
|
Salary
|
Bonus
|
Awards
(1)(2)
|
Compensation(3)
|
Total
|
||||||||||||||||||
Lyle
Jensen
Chief
Executive Officer
|
2008
2007
|
$ |
250,000
195,000 |
$ |
150,000
212,000 |
$ |
39,200
32,466
|
$ |
23,923
17,901
|
$ |
463,123
457,367 |
|||||||||||||
|
||||||||||||||||||||||||
Charles
E. Coppa
Chief
Financial Officer
|
2008
2007
|
$ |
158,625
150,000 |
$ |
75,000
51,000 |
$ |
--
10,533
|
$ |
12,760
11,912
|
$ |
246,385
223,445 |
(1)
|
Amounts shown do not reflect
compensation actually received by the named executive officer. The amounts
in the Option Awards column reflect the dollar amount recognized as
compensation cost for financial statement reporting purposes for the
fiscal years ended September
30, 2008 and September
30, 2007, in
accordance with SFAS 123(R) for all stock options granted in such fiscal years. The calculation in the table
above excludes all assumptions with respect to forfeitures. There can be
no assurance that the amounts set forth in the Option Awards column will
ever be realized. A forfeiture rate was used in the expense calculation in
the financial statements.
|
(2)
|
Options
granted have a ten-year term and vest at an annual rate of 20% over a
five-year period from the date of grant with the exception of the options
to purchase 225,000 shares granted to Mr. Jensen which pursuant to the
terms of his employment, vest immediately on the date of grant and have a
ten year term.
|
(3)
|
Represents
payments made to or on behalf of Messrs. Jensen and Coppa for health, life
and disability insurance and auto
allowances.
|
EBITDA
as
% of
Revenue
|
Performance
Incentive
|
|
Base:
|
10.0
% or Less
|
None
|
Level
I:
|
10.1%
– 12.0%
|
10%
of EBITDA dollars above Base
|
Level
II:
|
12.1%
– 15.0%
|
12%
of EBITDA dollars above Base
|
Level
III:
|
>
15.0%
|
15%
of EBITDA dollars above
Base
|
Number
of Securities Underlying
|
Exercise
|
Option
|
||||
Unexercised
Options
|
Price
|
Expiration
|
||||
Name
|
Date of
Grant
|
Exercisable
|
Unexercisable
|
Per
Share
|
Date
|
|
Lyle
Jensen
|
March
12, 2002 (1)
|
25,000
|
--
|
$1.51
|
March
12, 2012
|
|
August
23, 2002 (2)
|
2,500
|
--
|
$1.80
|
August
23, 2012
|
||
February
20, 2003 (3)
|
2,000
|
--
|
$1.95
|
February
20, 2013
|
||
April
24, 2004 (3)
|
2,000
|
--
|
$1.10
|
April
24, 2014
|
||
June
15, 2005 (3)
|
2,000
|
--
|
$0.51
|
June
15, 2015
|
||
April
12, 2006 (4)
|
300,000
|
200,000
|
$0.28
|
April
12, 2016
|
||
December
18, 2006 (4)
|
20,000
|
80,000
|
$0.35
|
December
18, 2016
|
||
December
29, 2006 (5)
|
25,000
|
--
|
$0.36
|
December
29, 2016
|
||
February
8, 2008 (5)
|
100,000
|
--
|
$0.34
|
February
8, 2018
|
||
September
30, 2008 (5)
|
100,000
|
--
|
$0.33
|
September
30, 2018
|
||
Charles
E. Coppa
|
July
22,1999 (2)
|
90,000
|
--
|
$0.53
|
July
22, 2009
|
|
February
18, 2000 (1)
|
100,000
|
--
|
$0.50
|
February
18, 2010
|
||
January 12,
2001 (2)
|
40,000
|
--
|
$0.40
|
January
12, 2011
|
||
August
23, 2002 (2)
|
7,500
|
--
|
$1.80
|
August
23, 2012
|
||
June
6, 2006 (4)
|
137,000
|
109,600
|
$0.36
|
June
6, 2016
|
||
September
28, 2007 (4)
|
45,000
|
45,000
|
$0.35
|
September
28,2017
|
(1)
|
These
options are non-qualified, have a ten-year term and vest at an
annual rate of 20% over a five-year period from the date of
grant
|
(2)
|
These
options were granted under the 1993 Stock Option Plan, have a ten-year
term and vest at an annual rate of 20% over a five-year period from the
date of grant
|
(3)
|
These
options were granted under the 1996 Non Employee Stock Option Plan, have a
ten-year term and vested immediately on the date of
grant.
|
(4)
|
These
options were granted under the 2005 Stock Option Plan, have a ten-year
term and vest at an annual rate of 20% over a five-year period from the
date of grant.
|
(5)
|
These
options were granted under the 2005 Stock Option Plan, have a ten-year
term and vested immediately on the date of
grant.
|
Name
|
Fees
Earned or Paid in
Cash or Common
Stock
|
Option
Awards
(1)
(2)
|
All
Other
Compensation
|
Total
|
Maury
Needham
|
$ --
|
$ --
|
$ --
|
$ --
|
Lew
Boyd
|
$ 17,500
|
$ --
|
$ --
|
$ 17,500
|
Dr.
Allen Kahn
|
$ 17,500
|
$ --
|
$ --
|
$ 17,500
|
Nick
DeBenedictis
|
$ 17,500
|
$ --
|
$ --
|
$ 17,500
|
(1)
|
There
were no option grants to Directors during fiscal
2008.
|
(2)
|
As of September 30, 2008, each
non-employee director holds the following aggregate number of shares under
outstanding stock options:
|
Name
|
Number
of Shares Underlying
Outstanding Stock Options |
Maury
Needham
|
578,962
|
Lew
Boyd
|
45,500
|
Dr.
Allen Kahn
|
51,500
|
Nick
DeBenedictis
|
235,000
|
Type
of Service
|
Amount
of Fee for
|
||
Fiscal
2008
|
Fiscal
2007
|
||
Audit
Fees
|
$
147,039
|
$
145,762
|
|
Audit-Related
Fees
|
36,833
|
10,828
|
|
Tax
Fees
|
35,913
|
30,300
|
|
Total
|
$
219,785
|
$
186,890
|
☐For all
nominees
☐Withhold authority for all
nominees
☐For all
except
(see instructions
below)
|
Nominees:
O
Maurice E. Needham
O
Lew F. Boyd
O
Dr. Allen Kahn
O
Lyle Jensen
|
For
|
Against
|
Abstain
|
|
☐
|
☐
|
☐
|
Signature
of Stockholder
|
Date:
|
Signature
of Stockholder
|
Date:
|